IAM
BNTC icon

Infinitum Asset Management’s Benitec Biopharma BNTC Stock Holding History

Infinitum Asset Management’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.83M Buy
923,006
+24,135
+3% +$279K 1.23% 15
2025
Q4 		$12.1M Buy
898,871
+398,871
+80% +$5.52M 1.79% 12
2025
Q3 		$7.01M Hold
500,000
– – 1.29% 16
2025
Q2 		$5.85M Sell
500,000
-625,000
-56% -$8.74M 1.3% 20
2025
Q1 		$18.9M Buy
1,125,000
+915,000
+436% +$11.1M 6.05% 5
2024
Q4 		$2.65M Buy
+210,000
New +$2.27M 1.4% 14

Other funds holding BNTC

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Infinitum Asset Management's BNTC Position: Q1 2026 in Review

Infinitum Asset Management increased its Benitec Biopharma (BNTC) stake by 2.7% in Q1 2026, buying an estimated $279K and bringing the position to 923,006 shares worth $9.83M. The position accounts for 1.23% of the portfolio, ranked #15.

Infinitum Asset Management first reported a position in BNTC in Q4 2024 and has held it in 6 quarters since. The position peaked at $18.9M in Q1 2025. 88 funds tracked by Wall St. Rank hold BNTC as of Q1 2026.

  • Infinitum Asset Management held 923,006 shares of Benitec Biopharma worth $9.83M as of Q1 2026.
  • Infinitum Asset Management bought 24,135 Benitec Biopharma shares in Q1 2026, an estimated $279K.
  • Benitec Biopharma made up 1.23% of Infinitum Asset Management's portfolio in Q1 2026, its #15 holding.
  • Infinitum Asset Management first reported a position in Benitec Biopharma in Q4 2024 and has held it in 6 quarters since.
  • Infinitum Asset Management's Benitec Biopharma position peaked at $18.9M in Q1 2025.
  • 88 funds tracked by Wall St. Rank held Benitec Biopharma as of Q1 2026.

Based on Infinitum Asset Management's 13F filing for Q1 2026, filed 15 May 2026.